References
- Abenhaim L, Moride Y, Brenot F, et al, for the International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996; 335(9): 609–16
- Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337(9): 581–8 [Erratum, N Engl J Med 1997; 337(24): 1783]
- Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107(2): 216–23
- Kanemoto N, Sasamoto H. Pulmonary hemodynamics in primary pulmonary hypertension. Jpn Heart J 1979; 20(4): 395–405
- Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80(2): 353–60
- Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70(4): 580–7
- Goodman DJ, Harrison DC, Popp RL. Echocardiography features of primary pulmonary hypertension. Am J Cardiol 1974; 33(3): 438–43
- Moser KM, Page GT, Ashburn WL, et al. Perfusion lung scans provide a guide to which patients with apparent primary pulmonary hypertension merit angiography. West J Med 1988; 148(2): 167–70
- Child JS, Wolfe JD, Tashkin D, et al. Fatal lung scan in a case of pulmonary hypertension due to obliterative pulmonary vascular disease. Chest 1975; 67(3): 308–10
- Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104(1): 236–50
- Wagenvoort CA, Mulder PG. Thrombotic lesions in primary plexogenic arteriopathy: similar pathogenesis or complication? Chest 1993; 103(3): 844–9
- Pietra GG, Edwards WD, Kay JM, et al. Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 1989; 80(5): 1198–206
- Eisenberg PR, Lucore C, Kaufman L, et al. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation 1990; 82(3): 841–7
- Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327(2): 76–81
- Barst RJ, Rubin LJ, Long WA, et al, for the Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334(5): 296–302
- Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation 1995; 92(8): 2252–8